Dasiglucagon: A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia Results of Phase 3 Randomized Double-Blind Clinical Trial
Diabetes Care
.
2021 Apr 21;dc202995.
doi: 10.2337/DC20-2995.
Online ahead of print.
Authors
Thomas R Pieber
1
,
Ronnie Aronson
2
,
Ulrike Hövelmann
3
,
Julie Willard
4
,
Leona Plum-Mörschel
5
,
Kim M Knudsen
6
,
Benedikte Bandak
6
,
Ramin Tehranchi
6
Affiliations
1
Medical University of Graz, Graz, Austria thomas.pieber@meduigraz.at.
2
LMC Diabetes and Endocrinology, Toronto, Ontario, Canada.
3
Profil, Neuss, Germany.
4
ProSciento, San Diego, CA.
5
Profil, Mainz, Germany.
6
Zealand Pharma, Søborg, Denmark.
PMID:
33883196
DOI:
10.2337/DC20-2995
No abstract available